Biosimilars: A Transatlantic Drift?
26 October 2017
Overview
With the first generation of biotherapeutics agents now nearing or having reached patent expiry, the potential for follow-on biotherapeutics is now presenting industry and regulatory bodies with novel challenges.
Download Quotient Sciences' scientific poster resource entitled 'Biosimilars: A Transatlantic Drift?' and contact our experts today to find out more.